
CTXR Valuation
Citius Pharmaceuticals Inc
- Overview
- Forecast
- Valuation
- Earnings
CTXR Relative Valuation
CTXR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CTXR is overvalued; if below, it's undervalued.
Historical Valuation
Citius Pharmaceuticals Inc (CTXR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.47 is considered Undervalued compared with the five-year average of -5.65. The fair price of Citius Pharmaceuticals Inc (CTXR) is between 7.68 to 11.28 according to relative valuation methord. Compared to the current price of 1.67 USD , Citius Pharmaceuticals Inc is Undervalued By 78.25%.
Relative Value
Fair Zone
7.68-11.28
Current Price:1.67
78.25%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.24
P/B
Median3y
1.23
Median5y
1.58
-124.68
FCF Yield
Median3y
-57.91
Median5y
-40.78
Competitors Valuation Multiple
The average P/S ratio for CTXR's competitors is 8.78, providing a benchmark for relative valuation. Citius Pharmaceuticals Inc Corp (CTXR) exhibits a P/S ratio of 0.48, which is -94.56% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch

ANY
Sphere 3D Corp
0.658
USD
-4.22%

TURB
Turbo Energy SA
2.270
USD
+0.44%

AXIL
AXIL Brands Inc
7.910
USD
-1.06%

CRIS
Curis Inc
1.840
USD
0.00%

BGI
Birks Group Inc
0.880
USD
-3.30%

HUBC
Hub Cyber Security Ltd
3.550
USD
-7.07%

AQU
Aquaron Acquisition Corp
0
USD
-0.60%

CGTX
Cognition Therapeutics Inc
0.840
USD
-2.55%

HOVR
New Horizon Aircraft Ltd
1.630
USD
0.00%

PMEC
Primech Holdings Ltd
1.470
USD
-2.00%
FAQ

Is Citius Pharmaceuticals Inc (CTXR) currently overvalued or undervalued?
Citius Pharmaceuticals Inc (CTXR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.47 is considered Undervalued compared with the five-year average of -5.65. The fair price of Citius Pharmaceuticals Inc (CTXR) is between 7.68 to 11.28 according to relative valuation methord. Compared to the current price of 1.67 USD , Citius Pharmaceuticals Inc is Undervalued By 78.25% .

What is Citius Pharmaceuticals Inc (CTXR) fair value?

How does CTXR's valuation metrics compare to the industry average?

What is the current P/B ratio for Citius Pharmaceuticals Inc (CTXR) as of Jul 27 2025?

What is the current FCF Yield for Citius Pharmaceuticals Inc (CTXR) as of Jul 27 2025?

What is the current Forward P/E ratio for Citius Pharmaceuticals Inc (CTXR) as of Jul 27 2025?
